SEARCH OUR PRODUCT CATALOG

ATP2B4-ERBB4 Fusion FISH Probe

The ATP2B4-ERBB4 Fusion FISH Probe is used to confirm a fusion of the ATP2B4 and ERBB4 genes. The fusion of the ATP2B4 and ERBB4 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
ATP2B4-ERBB4-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-RERE 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-REOR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-REGO 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-REGR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-REAQ 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-ORRE 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-OROR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-ORGO 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-ORAQ 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GORE 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GOOR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GOGO 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GOGR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GOAQ 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GRRE 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GROR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GRGO 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GRGR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-GRAQ 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-AQRE 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-AQOR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-AQGO 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-AQGR 20 (40 μL) 200 μL
ATP2B4-ERBB4-20-AQAQ 20 (40 μL) 200 μL

ATP2B4 Gene Summary

The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Gene Name: ATPase Plasma Membrane Ca2+ Transporting 4

Chromosome: CHR1: 203595914 -203713209

Locus: 1q32.1

ERBB4 Gene Summary

This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]

Gene Name: Erb-b2 Receptor Tyrosine Kinase 4

Chromosome: CHR2: 212240441 -213403352

Locus: 2q34

Gene Diseases

The ATP2B4 ERBB4 Fusion has been associated with the following diseases:

Disease Name
Lung Adenocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma

Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are two tumors that are difficult to distinguish from one another. It is important to distinguish them because ChRCC is a malignant tumor whereas RO is a benign tumor. Deletion of the RB1 and ERBB4 genes are indicative of ChRCC because these are tumor-suppressant genes. FISH analysis was used to identify these deletions. Our dual color probes were used that targeted RB1-Orange (MAC clone RP11-893E5) and 13q11-Green (RP11-408E5). A green ERBB4 probe was also used.

The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma

Renal oncocytoma (RO) is a benign epithelial neoplasm that makes up about 5 to 9% of all renal cell tumors. RO can be difficult to distinguish from a closely related but malignant counterpart, chromophobe renal cell carcinoma (ChrCC). This study used both IHC and FISH to detect the presence of RB1 and ERBB4, two genes that have been found deleted in ChrCC but not RO. A total of 28 ChrCCs and 25 RO cases were tested. Empire Genomics’ RB1 and ERBB4 FISH probes were used to detect deletions in these genes.